1 / 42

Depression and Psychopharm

Depression and Psychopharm. How Medications work and which to choose. Suicide (approximately 1 in 10 of those with depression). Antoine Wiertz (1806-1865). http://www.modjourn.brown.edu/mjp/Image/Wiertz/Wiertz.htm. Your client may need a medication consultation for anti-depressants if:.

jon
Download Presentation

Depression and Psychopharm

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Depression and Psychopharm How Medications work and which to choose

  2. Suicide (approximately 1 in 10 of those with depression) Antoine Wiertz (1806-1865) http://www.modjourn.brown.edu/mjp/Image/Wiertz/Wiertz.htm

  3. Your client may need a medication consultation for anti-depressants if: • Not so much a characterological depression as a physiological depression • Sleep, sex, and/or appetite disturbance • Fatigue • Agitation or psychomotor retardation • Anhedonia • Dysthymia is really sucking the energy out of them • Grief/heartbreak becomes depression • Psychotherapy isn’t helping • Suicidality • Daily functioning is markedly impaired • Always assess for Hypomania and Mania

  4. Anti-depressants Cymbalta No prescription is required as we ship from outside the United States.

  5. Antidepressants: Have only been around since the 1950’s Fall into categories: MAOIs TCAs SSRIs Atypical: SNRI, NSRI, etc.

  6. MAOIs (antuberculosis) • Powerful Antidepressants that also work with panic disorder and social phobia • The original Antidepressants • Inhibit enzymes that destroy serotonin, norepinephrine, and Dopamine

  7. Problems with MAOIs • Foods rich in tyramine are fatal • Avoid aged cheese; aged or cured meats (e.g., air-dried sausage); any potentially spoiled meat, poultry, or fish; broad (fava) bean pods; Marmite concentrated yeast extract; sauerkraut; soy sauce and soy bean condiments; and tap beer. • Listed in book

  8. TCAs • Some work as anti OCD and Antipanic • Block reuptake pump for 5HT, NE, and to a lesser extent Dopamine. (level of blockage for each NT is dependent on the medication) BUT ALSO……

  9. TCAs: • BLOCK • Muscarinic Cholinergic receptors • Dry mouth, blurred vision, urinary retention, constipation • H1 Histamine receptors • Sedation and weight gain • Alpha 1 adrenergic receptors • Hypotension and dizziness • Sodium channels in the heart and brain • Overdose will cause seizures, cardiac arrest, or arrhythmias

  10. Selectivity and the SSRIs • Depending on where the neuron goes and what receptors are blocked will change the effects of the drug • Currently we can’t control where the drug goes in the brain, but selectivity demonstrates better control over which receptors are blocked

  11. SSRIs • Block serotonin reuptake selectively-thus limited danger in overdose • Less side effects (only 5HT ones such as nausia, insomnia, headache, gastrointestinal, sweating, anxiety, restlessness • Initial anxiety and difficulty with sleep is common • AND…sexual side effects are a big problem • Additional difficulties into tx of fatigue and apathy should be monitored and treated with adjunct medication…For example Dopamine or NE meds….

  12. The current hypothesis is: People may have a NE deficiency and show symptoms of • Poor attention • Poor concentration • Poor working memory • Poor speed of information processing • Psychomotor retardation • Fatigue • Apathy • Depressed mood

  13. Or a 5HT deficiency and have symptoms of • Depressed mood • Anxiety • Phobias • Panic • OCD symptoms • Food cravings and Bulimia • How does this knowledge help you help your client?

  14. Other antidepressants • SNRIs block 5ht and NE reuptake • NRIs block NE reuptake (not available in US) • Atypical: Welbutrin (works on Dopamine and NE in complex way), Serzone (off the market), BuSpar, Remeron (no sexual, anxiety or nausia, but weight gain and sedation), Effexor (1:30), Milnacipran (1:3) (not in us), and cybalta • 1 + 1 = 3

  15. Other notes • Trazodone: For sleep, reduces SSRI side effects of insomnia and agitation and enhances SSRI effect • Can cause priapism in men • Can cause nightmares • What diagnosis would caution the use of this medication Keep in mind that because SSRIs inhibit enzyme 2D6, they increase levels of TCAs in Plasma

  16. Some bad mixtures • Luvox with atypical antidepressants, theophylline (for chronic asthma), and even caffeine can lead to seizures • Prozac and Luvox inhibit enzyme 3A4; Xanax, Halcion, and Propulsid (heartburn) are substrates of 3A4 and can become toxic causing cardiovascular trouble or sudden death

  17. Other Issues • Drugs can increase (induce) enzymes in the liver too. • For example: Tegretol induces 3A4 and is broken down by 3A4. Thus doses must be monitored and increased to avoid breakthru symptoms • And if Tegretol is stopped, any other drug metabolized by 3A4 will increase their concentration in the plasma (217)

  18. Did I cover these topics? Luvox,- addresses ruminations and OCD symptoms Welbutrin and other drugs for sexual side effects Reboxitine Stimulants Providual, Lexapro, Paxil & Luvox (ACH)

  19. Poor medication adherence is prevalent 1 out of 3 did not take antidepressant as directed within the first 30 days More than half (56%) did not adhere within four months! Reasons for non-adherence Side effects Belief that meds were not necessary Medication not working Forgot to take meds. Cost ($75 to $250/month) Primary Care Patients with Depression

  20. If clinicians closely monitor/manage side effects: • It may enhance compliance with medication • Adequate dosing = better for patient • Patients may not prematurely abandon therapy

  21. Sexual Dysfunction During Antidepressant Treatment • Is a huge problem and underreported in studies. Studies are less likely to address effects in women, which are different than in men • Diminished or absent libido • Arousal difficulties • Erectile dysfunction (in men) • Delayed orgasm • Anorgasmia • Or...undesirable sexual arousal and hypersexuality • Sexual partner may not understand

  22. Potential Consequences of Sexual Dysfunction • Psychological distress • Reduced quality of life • Self-esteem plummets • Sexual partner still doesn’t understand and relationships may dissolve with blame • Diminished motivation to get intimate with people • Non-compliant with medication

  23. A major obstacle in effective treatment of depression (and other disorders) is medication non-adherenece. • What do you do about it? Follow through with your clients! • Tell them what you know • Help them formulate what they’d like to discuss with doctor • Call or ask them to call a doctor and make an appointment • Obtain a release to talk to client’s doctor • Call doctor to introduce self and collaborate treatment

  24. So your client has a prescription for anti-depressant medication • Ask client for name and dosage • Assess client’s attitude, feelings, and thoughts about prescription • What is client’s response to meds? • Discuss side effects, discuss research, discuss options…discuss… • Encourage them to keep in contact with physician

  25. Race and Anti-depressants • Comparative, two month, pilot study investigating efficacy of Zoloft (Sertraline) found individuals (n=20) with a Chinese heritage: • Responded at a lower dose than Caucasians • One study (Melfi et al. 2000) found that African-Americans/blacks were less likely than whites to receive an antidepressant when their depression was first diagnosed (27% versus 44%). • Of those who did receive antidepressant medications, African Americans were less likely to receive the newer selective serotonin reuptake inhibitor (SSRI) medications than were the white clients. • African-Americans may require lower doses of medication because of metabolic differences (most research has been done on white populations e.g., heart disease study) http://www.depressionet.com.au/articles/251004efod.html

  26. Latinos and Mental Health – Study’s show… • Fewer than 1 in 11 contact mental health specialists, while fewer than 1 in 5 contact general health care providers. • Among Latino immigrants with mental disorders, fewer than 1 in 20 use services from mental health specialists, while fewer than 1 in 10 use services from general health care providers (Mental Health, 2001). • One study found that 24 percent of African-American/Blacks, & Hispanics with depression and anxiety received appropriate care, compared to 34 percent of Whites. • Another study found that Latinos who visited a general medical doctor were less than half as likely as Whites to receive either a diagnosis of depression or antidepressant medicine. • Further…..

  27. Physician-patient communication and Hispanic ethnicity • Physicians were more likely to state information to patients who started on new anti-depressants • Physicians were more likely to give information about anti-depressants to Whites than to Hispanics • 1 in 5 patients were asked how well their anti-depressants were working • 1 in 10 patients were asked if they were experiencing side effects • Hispanics were less likely than Whites to talk about their anti-depressants • Remember that research is rarely racially specific. • What does this implicate in working with Diverse Populations? Sleath B, Rubin RH, Huston SA Compr Psychiatry. 2003 May-Jun;44(3):198-204

  28. Discuss/role-play how these client factors may affect how you communicate about depression and anti-depressants • Sex and Gender • Age • Race • Ethnicity • Nationality • Religion • Learning style • Socio-economic status • Personality and attitude about medication

  29. Latinos and Suicide • In 2001, Latinos had a suicide rate of 5 per 100,000 compared to nearly 12 per 100,000 for Whites. • However, in the 2003 Youth Risk Behavioral Surveillance System, Latino students (10.6 percent) were more likely than White students (6.9 percent) to have reported a suicide attempt. • Latino students were more likely to have made a suicide plan (17.6 percent) than White males (16.2 percent). • Latino female students (5.7 percent) were significantly more likely than White female students (2.4 percent) to attempt suicide and require medical attention.

More Related